Your browser doesn't support javascript.
loading
Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care.
Mian, M N; Sarovar, V; Levine, T; Lea, A; Leibowitz, A; Luu, M; Flamm, J; Hare, C B; Horberg, M; Young-Wolff, K C; Phillips, K T; Silverberg, M J; Satre, D D.
Afiliação
  • Mian MN; Division of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
  • Sarovar V; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
  • Levine T; Division of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
  • Lea A; Division of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
  • Leibowitz A; Division of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
  • Luu M; Division of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
  • Flamm J; Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.
  • Hare CB; Kaiser Permanente Sacramento Medical Center, Sacramento, CA, USA.
  • Horberg M; Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
  • Young-Wolff KC; Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, MD, USA.
  • Phillips KT; Division of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
  • Silverberg MJ; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
  • Satre DD; Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, HI, USA.
Res Sq ; 2024 May 29.
Article em En | MEDLINE | ID: mdl-38853848
ABSTRACT

Background:

While cannabis use is prevalent among people with HIV (PWH), factors associated with higher-risk use require further study. We examined factors associated with indicators risk for cannabis use disorder (CUD) among PWH who used cannabis.

Methods:

Participants included adult (≥18 years old) PWH from 3 HIV primary care clinics in Kaiser Permanente Northern California who reported past three-month cannabis use through the computerized Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) screening. Primary outcome was TAPS cannabis score (range 1-3), categorized as any use (1) and higher risk for CUD (≥2). Measures included sociodemographics (age, sex, race, neighborhood deprivation index [NDI]), Charlson Comorbidity Index (CCI), HIV RNA, CD4 cell counts, higher risk tobacco use (TAPS tobacco score≥2), depression, and anxiety symptoms. Unadjusted and multivariable logistic regression examined factors associated with higher risk for CUD.

Results:

Of the complete sample (N=978; 94.1% Male; 58.3% White; Age Mode=51-60), 35.8% reported higher risk for CUD. Unadjusted models indicated younger age, Black race, higher CCI, depression, anxiety, and higher risk tobacco use were associated with higher risk, while only Black race (OR=1.84, 95% CI[1.29, 2.63]), anxiety (OR=1.91, 95% CI[1.22, 2.98]), and higher risk tobacco use (OR=2.27, 95% CI[1.47, 3.51]) remained significant in the multivariable model.

Conclusions:

Black race, anxiety and tobacco use, but not HIV clinical markers, were associated with higher risk for CUD among PWH. Clinical efforts to screen and provide interventions for preventing CUD alongside anxiety and tobacco use among PWH should be evaluated.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Res Sq Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Res Sq Ano de publicação: 2024 Tipo de documento: Article